Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer

D. N. Danforth, Marc E Lippman, H. McDonald, J. Bader, E. Egan, M. Lampert, S. M. Steinberg, S. M. Swain

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Mastectomy is frequently performed after intensive chemotherapy for locally advanced breast cancer. The effects of preoperative chemotherapy on the postoperative course and the timing of subsequent adjuvant therapy, however, have not been defined. We therefore reviewed the perioperative course of 54 patients undergoing mastectomy after combination (CAMFPT) chemotherapy for stage III(A,B) (III(A) - 25 pts; III(B) noninflammatory - 5 pts; III(B) inflammatory 24 patients) breast cancer. A median of 7 cycles (6 months) of chemotherapy was administered preoperatively. Mastectomy was performed a median of 20 days after last chemotherapy; white blood cell count (WBC) and platelet counts returned to normal limits preoperatively. Total mastectomy with or without axillary node dissection was performed in 53 patients, and a Halsted radical mastectomy in 1 patient. Negative margins on breast and/or axillary tissue were achieved in 47 patients (87.0%). Postoperative complications included skin flap necrosis in 8 patients (14.8%), seroma formation in 5 patients (9.3%), and wound infection in 1 patient (1.9%). Median operative blood loss (550 cc), hospital stay (8 days), and duration of wound catheter drainage (6 days) were comparable to published reports for modified radical mastectomy without preoperative chemotherapy. Systemic chemotherapy was resumed a median of 16 days after mastectomy, and radiotherapy started a median of 33 days after mastectomy. These findings indicate that intensive preoperative chemotherapy does not increase the hospital course or the postoperative complications of mastectomy for locally advanced breast cancer. In view of the current interest in treatment of stage I and II breast cancer with preoperative chemotherapy, this information may be useful in their management as well.

Original languageEnglish
Pages (from-to)6-11
Number of pages6
JournalAmerican Surgeon
Volume56
Issue number1
StatePublished - Jan 1 1990
Externally publishedYes

Fingerprint

Mastectomy
Breast Neoplasms
Drug Therapy
Radical Mastectomy
Simple Mastectomy
Modified Radical Mastectomy
Seroma
Wound Infection
Combination Drug Therapy
Platelet Count
Leukocyte Count
Dissection
Drainage
Length of Stay
Breast
Necrosis
Radiotherapy
Blood Platelets
Catheters
Skin

ASJC Scopus subject areas

  • Surgery

Cite this

Danforth, D. N., Lippman, M. E., McDonald, H., Bader, J., Egan, E., Lampert, M., ... Swain, S. M. (1990). Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer. American Surgeon, 56(1), 6-11.

Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer. / Danforth, D. N.; Lippman, Marc E; McDonald, H.; Bader, J.; Egan, E.; Lampert, M.; Steinberg, S. M.; Swain, S. M.

In: American Surgeon, Vol. 56, No. 1, 01.01.1990, p. 6-11.

Research output: Contribution to journalArticle

Danforth, DN, Lippman, ME, McDonald, H, Bader, J, Egan, E, Lampert, M, Steinberg, SM & Swain, SM 1990, 'Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer', American Surgeon, vol. 56, no. 1, pp. 6-11.
Danforth DN, Lippman ME, McDonald H, Bader J, Egan E, Lampert M et al. Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer. American Surgeon. 1990 Jan 1;56(1):6-11.
Danforth, D. N. ; Lippman, Marc E ; McDonald, H. ; Bader, J. ; Egan, E. ; Lampert, M. ; Steinberg, S. M. ; Swain, S. M. / Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer. In: American Surgeon. 1990 ; Vol. 56, No. 1. pp. 6-11.
@article{f917f62ed8bd42be804b2518a3c99bcc,
title = "Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer",
abstract = "Mastectomy is frequently performed after intensive chemotherapy for locally advanced breast cancer. The effects of preoperative chemotherapy on the postoperative course and the timing of subsequent adjuvant therapy, however, have not been defined. We therefore reviewed the perioperative course of 54 patients undergoing mastectomy after combination (CAMFPT) chemotherapy for stage III(A,B) (III(A) - 25 pts; III(B) noninflammatory - 5 pts; III(B) inflammatory 24 patients) breast cancer. A median of 7 cycles (6 months) of chemotherapy was administered preoperatively. Mastectomy was performed a median of 20 days after last chemotherapy; white blood cell count (WBC) and platelet counts returned to normal limits preoperatively. Total mastectomy with or without axillary node dissection was performed in 53 patients, and a Halsted radical mastectomy in 1 patient. Negative margins on breast and/or axillary tissue were achieved in 47 patients (87.0{\%}). Postoperative complications included skin flap necrosis in 8 patients (14.8{\%}), seroma formation in 5 patients (9.3{\%}), and wound infection in 1 patient (1.9{\%}). Median operative blood loss (550 cc), hospital stay (8 days), and duration of wound catheter drainage (6 days) were comparable to published reports for modified radical mastectomy without preoperative chemotherapy. Systemic chemotherapy was resumed a median of 16 days after mastectomy, and radiotherapy started a median of 33 days after mastectomy. These findings indicate that intensive preoperative chemotherapy does not increase the hospital course or the postoperative complications of mastectomy for locally advanced breast cancer. In view of the current interest in treatment of stage I and II breast cancer with preoperative chemotherapy, this information may be useful in their management as well.",
author = "Danforth, {D. N.} and Lippman, {Marc E} and H. McDonald and J. Bader and E. Egan and M. Lampert and Steinberg, {S. M.} and Swain, {S. M.}",
year = "1990",
month = "1",
day = "1",
language = "English",
volume = "56",
pages = "6--11",
journal = "The American surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "1",

}

TY - JOUR

T1 - Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer

AU - Danforth, D. N.

AU - Lippman, Marc E

AU - McDonald, H.

AU - Bader, J.

AU - Egan, E.

AU - Lampert, M.

AU - Steinberg, S. M.

AU - Swain, S. M.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Mastectomy is frequently performed after intensive chemotherapy for locally advanced breast cancer. The effects of preoperative chemotherapy on the postoperative course and the timing of subsequent adjuvant therapy, however, have not been defined. We therefore reviewed the perioperative course of 54 patients undergoing mastectomy after combination (CAMFPT) chemotherapy for stage III(A,B) (III(A) - 25 pts; III(B) noninflammatory - 5 pts; III(B) inflammatory 24 patients) breast cancer. A median of 7 cycles (6 months) of chemotherapy was administered preoperatively. Mastectomy was performed a median of 20 days after last chemotherapy; white blood cell count (WBC) and platelet counts returned to normal limits preoperatively. Total mastectomy with or without axillary node dissection was performed in 53 patients, and a Halsted radical mastectomy in 1 patient. Negative margins on breast and/or axillary tissue were achieved in 47 patients (87.0%). Postoperative complications included skin flap necrosis in 8 patients (14.8%), seroma formation in 5 patients (9.3%), and wound infection in 1 patient (1.9%). Median operative blood loss (550 cc), hospital stay (8 days), and duration of wound catheter drainage (6 days) were comparable to published reports for modified radical mastectomy without preoperative chemotherapy. Systemic chemotherapy was resumed a median of 16 days after mastectomy, and radiotherapy started a median of 33 days after mastectomy. These findings indicate that intensive preoperative chemotherapy does not increase the hospital course or the postoperative complications of mastectomy for locally advanced breast cancer. In view of the current interest in treatment of stage I and II breast cancer with preoperative chemotherapy, this information may be useful in their management as well.

AB - Mastectomy is frequently performed after intensive chemotherapy for locally advanced breast cancer. The effects of preoperative chemotherapy on the postoperative course and the timing of subsequent adjuvant therapy, however, have not been defined. We therefore reviewed the perioperative course of 54 patients undergoing mastectomy after combination (CAMFPT) chemotherapy for stage III(A,B) (III(A) - 25 pts; III(B) noninflammatory - 5 pts; III(B) inflammatory 24 patients) breast cancer. A median of 7 cycles (6 months) of chemotherapy was administered preoperatively. Mastectomy was performed a median of 20 days after last chemotherapy; white blood cell count (WBC) and platelet counts returned to normal limits preoperatively. Total mastectomy with or without axillary node dissection was performed in 53 patients, and a Halsted radical mastectomy in 1 patient. Negative margins on breast and/or axillary tissue were achieved in 47 patients (87.0%). Postoperative complications included skin flap necrosis in 8 patients (14.8%), seroma formation in 5 patients (9.3%), and wound infection in 1 patient (1.9%). Median operative blood loss (550 cc), hospital stay (8 days), and duration of wound catheter drainage (6 days) were comparable to published reports for modified radical mastectomy without preoperative chemotherapy. Systemic chemotherapy was resumed a median of 16 days after mastectomy, and radiotherapy started a median of 33 days after mastectomy. These findings indicate that intensive preoperative chemotherapy does not increase the hospital course or the postoperative complications of mastectomy for locally advanced breast cancer. In view of the current interest in treatment of stage I and II breast cancer with preoperative chemotherapy, this information may be useful in their management as well.

UR - http://www.scopus.com/inward/record.url?scp=0025317715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025317715&partnerID=8YFLogxK

M3 - Article

C2 - 2153011

AN - SCOPUS:0025317715

VL - 56

SP - 6

EP - 11

JO - The American surgeon

JF - The American surgeon

SN - 0003-1348

IS - 1

ER -